# NIH Reporter #5K08HL166962-04

Aspirin for Primary Prevention of Cardiovascular Disease in Patients with Elevated Lipoprotein(a)

**Recipient:** University of California, San Diego

**Award Amount:** $168,912.00
**Ceiling:** $168,912.00

**Awarded:** September 09, 2026

**Identifier:** 5K08HL166962-04

NIH funded project to study low-dose aspirin's effectiveness in preventing cardiovascular disease in patients with high Lipoprotein(a) using existing clinical trial data and cohort studies.

### Description

This project aims to evaluate the efficacy of low-dose aspirin therapy in reducing atherosclerotic cardiovascular disease (ASCVD) events among individuals with elevated Lipoprotein(a) [Lp(a)]. The study involves secondary analyses of existing clinical trials (ASCEND and ASPREE) and prospective cohort studies with diverse ethnic populations in the United States.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11401147)